about
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease...
Read More
17.22
0.03
(0.17%)
15,641
XNAS Volume
XNAS 10 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Oculis Holding AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..